Advertisement

HIV Care Today


Must-Read Item: This Year's JAMA HIV/AIDS Issue
By Paul E. Sax, M.D.
July 14, 2016

The folks over at the Journal of the American Medical Association have been doing a periodic HIV/AIDS themed issue for years, generally around the time of the International AIDS Conference. The latest issue is out this week, and it's terrific.

Read more …


Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially for Genotypes 2 and 3
By Paul E. Sax, M.D.
July 3, 2016

One of the ways ID and hepatology hepatitis C experts like to show off is by discoursing on the nuances of cleverly named clinical trials, and how these impact treatment guidelines.

Read more …


Drug Prior Authorizations Are a Very Blunt Tool for Cost Containment -- And They're Annoying
By Paul E. Sax, M.D.
May 22, 2016

Insurance prior authorizations, or prior approvals (PAs) -- those dreaded forms clinicians have to fill out, usually triggered by prescribing a non-formulary drug -- are much on my mind these days. And most of it has to do with three letters, specifically "TAF."

Read more …


Why Getting Old Isn't Always so Terrible -- and Why People With HIV Can Now Get Life Insurance
By Paul E. Sax, M.D.
April 24, 2016


Two patient-related anecdotes, then a news item.

Read more …


Zika and HIV: Connecting the Science
By Artur Timerman, M.D.
March 17, 2016

In my first years of medical practice, dealing with AIDS at that time was invariably fatal. Years later, still battling HIV, we are now faced with another outbreak of a similar nature -- the Zika virus. I remember the time when we did not have a clinical-epidemiological diagnosis of a new disease. I remember the era when we did not have a precise etiologic diagnosis. I remember a time when we had not yet discovered the virus responsible for AIDS. Pathogenesis was discussed by inferences but it took us four years to discover HIV (then HTLV-III or LAV) and even more time to understand how it caused immunodeficiency, although a lot still needs to be learned.

Read more …


Approval of TAF/FTC/RPV, Another Single Pill HIV Treatment Option
By Paul E. Sax, M.D.
March 9, 2016

The approval last week of TAF/FTC/RPV -- that's coformulated tenofovir alafenamide, emtricitabine, and rilpivirine -- brings us another one-pill, once-daily option for HIV treatment.

Read more …


Twelve Zika Questions, One HIV Doctor's Answers (Sort Of)
By Paul E. Sax, M.D.
February 7, 2016

Got a Zika question? Welcome to the club -- once again, as with any "new" or "emerging" infection, this is uncharted territory, and there are plenty of answers to these questions that could be summarized with 3 words: We Don't Know.

Read more …


A Doctor's Perspective: Care Then and Now
By Philip Berger, M.D.
Winter 2016

These peculiar infections resolved, and the doctors just attributed these temporary illnesses to another infection picked up in the bathhouses or through needle sharing on the streets. No one put these individual cases together and wondered whether some common condition could explain their individual patients' illnesses. Yet an epidemic -- the AIDS epidemic -- was exploding before our very eyes.

Read more …


IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon
By Paul E. Sax, M.D.
January 18, 2016

Something interesting happens when you poll people who treat HIV -- and people who have HIV -- about whether they'd prefer a treatment option that consists of a periodic injection or infusion in place of the pill or pills that they take every day.

Read more …


Medical Marijuana and Painful Neuropathy -- An Opportunity to Make Us Believers
By Paul E. Sax, M.D.
January 10, 2016

Medical marijuana is now officially available in New York, the city with by far the largest number of people living with HIV/AIDS in the country. Reporting on the first dispensary in Manhattan, the aptly named Julie Weed (yes! her real name!) writes:

Read more …

 1  |  2  |  3  |  …  |  19  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.com.
 

Advertisement